본문으로 건너뛰기
← 뒤로

[Research progress on prevention and treatment of hepatocellular carcinoma with traditional Chinese medicine based on gut microbiota].

1/5 보강
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2025 Vol.50(15) p. 4190-4200
Retraction 확인
출처

Ren R, Yang X, Ren PP, Bi Q, DU BZ, Zhang QY, Wang XH, Jiang ZQ, Liang JX, Shao MY

📝 환자 설명용 한 줄

Hepatocellular carcinoma(HCC), the third leading cause of cancer-related death worldwide, is characterized by high mortality and recurrence rates.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Ren R, Yang X, et al. (2025). [Research progress on prevention and treatment of hepatocellular carcinoma with traditional Chinese medicine based on gut microbiota].. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 50(15), 4190-4200. https://doi.org/10.19540/j.cnki.cjcmm.20250423.202
MLA Ren R, et al.. "[Research progress on prevention and treatment of hepatocellular carcinoma with traditional Chinese medicine based on gut microbiota].." Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, vol. 50, no. 15, 2025, pp. 4190-4200.
PMID 41084436

Abstract

Hepatocellular carcinoma(HCC), the third leading cause of cancer-related death worldwide, is characterized by high mortality and recurrence rates. Common treatments include hepatectomy, liver transplantation, ablation therapy, interventional therapy, radiotherapy, systemic therapy, and traditional Chinese medicine(TCM). While exhibiting specific advantages, these approaches are associated with varying degrees of adverse effects. To alleviate patients' suffering and burdens, it is crucial to explore additional treatments and elucidate the pathogenesis of HCC, laying a foundation for the development of new TCM-based drugs. With emerging research on gut microbiota, it has been revealed that microbiota plays a vital role in the development of HCC by influencing intestinal barrier function, microbial metabolites, and immune regulation. TCM, with its multi-component, multi-target, and multi-pathway characteristics, has been increasingly recognized as a vital therapeutic treatment for HCC, particularly in patients at intermediate or advanced stages, by prolonging survival and improving quality of life. Recent global studies demonstrate that TCM exerts anti-HCC effects by modulating gut microbiota, restoring intestinal barrier function, regulating microbial composition and its metabolites, suppressing inflammation, and enhancing immune responses, thereby inhibiting the malignant phenotype of HCC. This review aims to elucidate the mechanisms by which gut microbiota contributes to the development and progression of HCC and highlight the regulatory effects of TCM, addressing the current gap in systematic understanding of the "TCM-gut microbiota-HCC" axis. The findings provide theoretical support for integrating TCM with western medicine in HCC treatment and promote the transition from basic research to precision clinical therapy through microbiota-targeted drug development and TCM-based interventions.

MeSH Terms

Humans; Gastrointestinal Microbiome; Carcinoma, Hepatocellular; Liver Neoplasms; Drugs, Chinese Herbal; Animals; Medicine, Chinese Traditional

같은 제1저자의 인용 많은 논문 (4)